Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-06-02 17:20:34 ET · period of report 2026-06-01 · accession 0001159036-26-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-02 17:20 | 2026-06-01 | HALO | Connaughton Bernadette | Dir | S - Sale | $66.21 | -1,625 | 43.7K | -4% | -$107.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 1,625 | $66.21 | 43,669 | D | — | — | (F1) The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1. |